Outcomes Of The KEYNOTE 426 Phase III Study In mRCC

Outcomes Of The KEYNOTE 426 Phase III Study In mRCC

obr

1 year
52 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses Outcomes Of The KEYNOTE 426 Phase III Study In mRCC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019. http://obroncology.com
Up Next Autoplay